<p>A serial two-fold dilution of OVA<sub>257-264</sub>-liposome (open box) and OVA<sub>257-264</sub> solution (closed box) were made in PBS, and mice were immunized with the diluents in the presence of 5 µg CpG. OVA<sub>257-264</sub> solution containing equal amounts of peptides as those in OVA<sub>257-264</sub>-liposome. One week after the immunization, IFN-γ production by CD8<sup>+</sup> T cells (<b>A</b>) and the CTL response (<b>B</b>) were monitored as described in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0015091#s4" target="_blank">Materials and Methods</a>. Data represent means and SE of three mice per group. *, significant difference (p>0.01).</p
<p>(A, B) C57BL/6 mice were immunized by a single i.v. injection of 5×10<sup>7</sup> PFU BV-WT, BV-O...
<p>The DDA:TDB+OVA formulations indicated along the X-axis were given to C57/BL6 mice as three homol...
<p>Groups of 4 BALB/c mice were vaccinated with 10<sup>10</sup> vp/mouse of either PAV3-HA () or AdH...
<p>Mice were immunized with 50 µl of OVA<sub>257-264</sub>-liposome in the presence of 5 µg CpG, and...
<p>Mice with (closed box) or without (open box) CD4<sup>+</sup> T-cell elimination were immunized wi...
<p>(<b>A</b>) Intramuscular and subcutaneous vaccination with increasing doses of Adjuplex generate ...
<p>Mice were immunized with 50 µl of OVA<sub>257-264</sub>-liposome in the presence of 5 µg CpG; one...
<p>Mice were immunized with OVA<sub>257-264</sub>-liposome and 1 week or 20 weeks later, CD8<sup>+</...
<p>Number of transgenic Vα2<sup>+</sup>Vβ5<sup>+</sup> CD4<sup>+</sup> (A) and Vα2<sup>+</sup>Vβ5<su...
<p>CB6F1 mice were vaccinated once with Ad-H4, twice with rH4 in cationic liposomes, or once with rH...
<p>Six months after the last immunization mice from all groups (vaccination regimens are described i...
<p>C57BL/6 mice were immunized by a single i.v. injection of 5×10<sup>7</sup> PFU BV-WT, BV-OVA, BV-...
<p>Splenic CD4/CD8<sup>+</sup> T cells were taken from mice immunized with OVA and were cultured wit...
<p>C57BL/6 mice received CFSE-labeled, OVA-specific OT-I T cells (10<sup>7</sup>) <i>i.v.</i> Two da...
<p><b>A)</b> Total numbers of 2° M Thy1.1 P14 CD8 T cells in mL of PBL, and in the spleen, lung, and...
<p>(A, B) C57BL/6 mice were immunized by a single i.v. injection of 5×10<sup>7</sup> PFU BV-WT, BV-O...
<p>The DDA:TDB+OVA formulations indicated along the X-axis were given to C57/BL6 mice as three homol...
<p>Groups of 4 BALB/c mice were vaccinated with 10<sup>10</sup> vp/mouse of either PAV3-HA () or AdH...
<p>Mice were immunized with 50 µl of OVA<sub>257-264</sub>-liposome in the presence of 5 µg CpG, and...
<p>Mice with (closed box) or without (open box) CD4<sup>+</sup> T-cell elimination were immunized wi...
<p>(<b>A</b>) Intramuscular and subcutaneous vaccination with increasing doses of Adjuplex generate ...
<p>Mice were immunized with 50 µl of OVA<sub>257-264</sub>-liposome in the presence of 5 µg CpG; one...
<p>Mice were immunized with OVA<sub>257-264</sub>-liposome and 1 week or 20 weeks later, CD8<sup>+</...
<p>Number of transgenic Vα2<sup>+</sup>Vβ5<sup>+</sup> CD4<sup>+</sup> (A) and Vα2<sup>+</sup>Vβ5<su...
<p>CB6F1 mice were vaccinated once with Ad-H4, twice with rH4 in cationic liposomes, or once with rH...
<p>Six months after the last immunization mice from all groups (vaccination regimens are described i...
<p>C57BL/6 mice were immunized by a single i.v. injection of 5×10<sup>7</sup> PFU BV-WT, BV-OVA, BV-...
<p>Splenic CD4/CD8<sup>+</sup> T cells were taken from mice immunized with OVA and were cultured wit...
<p>C57BL/6 mice received CFSE-labeled, OVA-specific OT-I T cells (10<sup>7</sup>) <i>i.v.</i> Two da...
<p><b>A)</b> Total numbers of 2° M Thy1.1 P14 CD8 T cells in mL of PBL, and in the spleen, lung, and...
<p>(A, B) C57BL/6 mice were immunized by a single i.v. injection of 5×10<sup>7</sup> PFU BV-WT, BV-O...
<p>The DDA:TDB+OVA formulations indicated along the X-axis were given to C57/BL6 mice as three homol...
<p>Groups of 4 BALB/c mice were vaccinated with 10<sup>10</sup> vp/mouse of either PAV3-HA () or AdH...